cremophor el has been researched along with chitosan in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhanikula, AB; Panchagnula, R; Singh, DR | 1 |
| Choi, K; Chung, H; Jeong, SY; Kim, IS; Kim, JH; Kim, K; Kim, S; Kim, YS; Kwon, IC; Park, JH; Park, RW | 1 |
| Allen, C; De Souza, R; Grant, J; Piquette-Miller, M; Vassileva, V | 1 |
| Huo, M; Li, H; Li, J; Wu, Y; Yu, D; Zhang, Y; Zhou, J; Zou, A | 1 |
| Cui, F; Gong, X; Li, Q; Liang, N; Sun, S; Yan, P | 1 |
5 other study(ies) available for cremophor el and chitosan
| Article | Year |
|---|---|
In vivo pharmacokinetic and tissue distribution studies in mice of alternative formulations for local and systemic delivery of Paclitaxel: gel, film, prodrug, liposomes and micelles.
Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Carbon Radioisotopes; Chitosan; Gels; Glycerol; Half-Life; Injections, Intravenous; Injections, Subcutaneous; Liposomes; Male; Mice; Micelles; Motion Pictures; Paclitaxel; Prodrugs; Tissue Distribution | 2005 |
Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Body Weight; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Glycerol; Humans; Hydrophobic and Hydrophilic Interactions; Injections, Intravenous; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanostructures; Paclitaxel; Technology, Pharmaceutical; Time Factors; Treatment Outcome | 2006 |
Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biocompatible Materials; Chitosan; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Carriers; Drug Implants; Eggs; Female; Glycerol; Humans; Injections, Intraperitoneal; Mice; Mice, Nude; Ovarian Neoplasms; Paclitaxel; Phosphatidylcholines; Xenograft Model Antitumor Assays | 2007 |
Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug.
Topics: Animals; Antineoplastic Agents, Phytogenic; Chitosan; Dialysis; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Drug Stability; Female; Glycerol; Guinea Pigs; Magnetic Resonance Spectroscopy; Male; Maximum Tolerated Dose; Mice; Micelles; Paclitaxel; Solubility; Spectroscopy, Fourier Transform Infrared; Toxicity Tests, Acute | 2010 |
Polymeric Micelles Based on Modified Glycol Chitosan for Paclitaxel Delivery: Preparation, Characterization and Evaluation.
Topics: alpha-Tocopherol; Animals; Antineoplastic Agents; Chitosan; Drug Delivery Systems; Female; Glycerol; Humans; Injections, Intravenous; Male; MCF-7 Cells; Mice; Micelles; Paclitaxel; Particle Size; Polymers; Proton Magnetic Resonance Spectroscopy; Rabbits; Spectroscopy, Fourier Transform Infrared; Static Electricity; X-Ray Diffraction | 2018 |